Patient Support Programs—Providing Help Beyond Financial Support
Posted by | Fuld & Company
Varun Naik was called upon by PM360 to share best practices on Effectively Developing a Patient Support Program by Leveraging Competitive Intelligence (CI) tactics. He also covers this topic broadly in a Fuld & Company whitepaper.
An effective PSP is critical to a drug’s success and requires significant resources to develop and manage.
Therefore, organizations must make the right investment decisions with a focus on the patient’s needs, especially as patients play a stronger role in their treatment decisions. Executives must also identify elements that create exceptional value for patients and meet the needs of healthcare offices.
Developing a robust strategy for a patient support program begins with assessing the current environment.
By benchmarking existing programs and pinpointing their areas of improvement, companies can leverage insights to refine their approach and create a competitive advantage. While all programs tend to include the same basic elements, there is no one size fits all approach, as experiences differ by indication. However, some success criteria Fuld & Company has identified for all patient support programs are…
About Varun Naik
Varun Naik serves as Director in the Life Science Consulting practice at Fuld & Company. He specializes in rare disease, biosimilars and other pharma related topics.
Tags: BioPharma, Competitive Intelligence, Health & Life Science, Pharmaceuticals
